J0175 Injection, donanemab-azbt, 2 milligrams
J-Codes
Also known as: donanemab, Kisunla
Donanemab-azbt injection 2 milligrams, a monoclonal antibody against amyloid-beta for Alzheimer's disease.
Clinical Context
Intravenous monoclonal antibody targeting amyloid-beta for early symptomatic Alzheimer's disease. Designed with longer half-life for less frequent dosing than some alternatives.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.